ConductScience.org, home

Paper32155673

A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes.

Chen D and 13 others. Clin Exp Pharmacol Physiol, 2020. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes. Papers, record 32155673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32155673

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes.
PubMed
Journal
Clin Exp Pharmacol Physiol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2024-07-24
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen DDeqihttps://orcid.org/0000-0001-9377-0116
2Jia DDan
3Wu XXia
4Shi KKexin
5Ren CCui
6Dou YYonghui
7Guo MMingxin
8Wang JJuanxia
9Ma MMin
10Wu ZZhengzhi
11Shi HYHe-Yong
12Li WWeiminhttps://orcid.org/0000-0002-9377-7219
13Feng YYifan
14Wu FFuhai

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Lipid MetabolismMajor topic
MetforminMajor topic
ObesityMajor topic
Animals
Rats
Male
Hypoglycemic Agents
Liver
Insulin Resistance
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
39596174Investigating the Effects of Gossypetin on Cardiovascular Function in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats.Int J Mol Sci2024https://conductscience.org/library/papers/39596174PubMed
36297575Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications.Pharmaceutics2022https://conductscience.org/library/papers/36297575PubMed
35267644Metformin Intervention-A Panacea for Cancer Treatment?Cancers (Basel)2022https://conductscience.org/library/papers/35267644PubMed
34668415Metformin prevents airway hyperreactivity in rats with dietary obesity.Am J Physiol Lung Cell Mol Physiol2021https://conductscience.org/library/papers/34668415PubMed
33859820Effects of obesity and 10 weeks metformin treatment on liver steatosis.Biomed Rep2021https://conductscience.org/library/papers/33859820PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32155673

GET https://conductscience.org/api/papers/v1/32155673/authors